Background
==========

Leukemoid reaction refers to a reactive leukocytosis, which has been described in response to inflammation, severe or disseminated infection, tissue destruction or other marrow stimulants. Leukemoid reaction is a sign for poor prognosis in solid tumors and so is sarcomatoid renal cell carcinoma (SRCC) when compared to more differentiated histologies. SRCC is a rare but very aggressive variant of renal cell carcinoma (RCC) which used to be thought of as a primary renal sarcoma. Since these tumors co-express both epithelial and stromal markers, they are now believed to represent a form of dedifferentiated carcinoma. As SRCC is highly resistant to chemotherapy and easily metastases, many patients died shortly after diagnosis. Leukemoid reactions have been described mainly in association with lung, gastrointestinal, bladder and head and neck cancers, but have rarely been described in association with SRCC. To our knowledge, these are the first two cases report to do so. The characteristics of both patients are described in Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}.

###### 

Baseline and clinical characteristics (Case 1)

  **Characteristics**                                       
  ----------------------- --------------------------------------------------------------------
  Age (year)                                               36
  Sex                                                    female
  BMI (Kg/m^2^)                                           22.5
  Tumor size (cm)                                          10
  TNM stage                                                 
   T                                                       T2
   N                                                       N1
   M                                                       M0
  Stage                                                   III
  Whole blood count                                         
   Red blood cell                                    3.43\*10\^12/L
   Hb                                                   102 g/L
   Platelet                                           110\*10\^9/L
   White blood cell                                  47.2\*10\^9/L
   NEUT%                                                  89.2
  Lactate dehydrogenase                                 1075 U/L
  Alkaline phosphatse                                   434 U/L
  Operation                                           nephrectomy
                           free margins with 2/7 positive lymph nodes in posterior peritoneum
  Immunohistology                                           
                                 CAM5.2(+)CD10(+)CD15(+)CEA(-)CK20(-)CK7(-)RCC(-)VIM(+)
  Reason for death                               multiple organ failure

###### 

Baseline demographic and clinical characteristics (Case 2)

  **Characteristics**                                       
  ----------------------- --------------------------------------------------------------------
  Age (year)                                               56
  Sex                                                     male
  BMI (Kg/m^2^)                                           24.5
  Tumor size (cm)                                          10
  TNM stage                                                 
   T                                                       T2
   N                                                       N0
   M                                                       M0
  Stage                                                    II
  Whole blood count                                         
   Red blood cell                                    3.23\*10\^12/L
   Hb                                                    98 g/L
   Platelet                                           258\*10\^9/L
   White blood cell                                  30.2\*10\^9/L
   NEUT%                                                  91.3
  Lactate dehydrogenase                                 558 U/L
  Alkaline phosphatse                                    289U/L
  Operation                                           nephrectomy
                           free margins with 0/5 negative lymph nodes in posterior peritoneum
  Immunhistology                                            
                           CAM5.2(+)EMA(-)SMA(+)DES(-)CgA(-)S-100(-)CK20(-)CK7(-)RCC(-)VIM(+)
  Reason for death                               multiple organ failure

Case presentation
=================

Case one
--------

A 36 year old woman presented with left flank pain for one month. The patient was admitted to the First Affiliated Hospital of Wenzhou Medical University and underwent serial examinations. Physical examination showed a left flank mass with tenderness. An abdominal computed tomography (CT) scan showed a mass measuring 8 × 10 cm in the left kidney (Figure [1](#F1){ref-type="fig"}A). Her initial white blood cell (WBC) count was 48 × 10^9^/l, she did not complain of fever, and her bone marrow smear did not show myeloproliferative process. A septic workup, including chest x-ray, blood culture, and urine culture were all negative. She underwent radical nephrectomy and the pathologic diagnosis was SRCC (Figure [2](#F2){ref-type="fig"}A). No complication developed and the course of treatment was uneventful. However, the WBC count gradually increased (Figure [3](#F3){ref-type="fig"}A) and the body temperature was high (37.9 to 40.5°C). She was treated with systemic antibiotics and the temperature decreased but the WBC count remained high. Due to the high WBC count, a workup for chronic myeloid leukemia (CML) was initiated. The lactic dehydrogenase (LDH) level was 351. The leukocyte alkaline phosphatase (LAP) score was 280. A peripheral smear showed numerous segmented neutrophils and bands. A bone marrow biopsy also provided no evidence supporting either a hematological neoplasia, or the presence of infiltration by tumor cells. Cytogenetic studies were normal. A PCR(Polymerase Chain Reaction) for BCR-ABL fusion transcript was negative. A diagnosis of a leukemoid reaction was confirmed and she died of multiple organ failure shortly there after at six weeks postoperatively.

![**Scans of the left kidney mass. A**. CT scan: a mass measuring 8 × 10 cm in the left kidney. **B**. MR: A giant abnorminal signal in the right kidney, measuring 9 × 10 cm. Hydronephrosis existed.](1477-7819-12-100-1){#F1}

![**Pathological examination of sarcomatoid renal cell carcinoma cells. A**. Sarcomatoid renal cell carcinoma was confirmed by the pathological examination. **B**. Sarcomatoid renal cell carcinoma was confirmed by the pathological examination.](1477-7819-12-100-2){#F2}

![**WBC count graphs showing WBC count was record down when patients were admitted to hospital**. **A**. WBC gradually increased postoperatively. Δ represents the first day patient underwent radical nephrectomy. ○ represents the day patient was discharged from hospital. **B**. WBC count gradually increased postoperatively. Δ represents the first day the patient underwent radical nephrectomy. ○ represents the day the patient was discharged from hospital. L, liter; WBC, white blood count.](1477-7819-12-100-3){#F3}

Case 2
------

The patient, a 56 year old male, complained about more than half a month's history of right flank pain and fever. He had no systemic and lower urinary tract symptoms and was admitted to the First Affiliated Hospital of Wenzhou Medical University for further examinations. The patient started with a high fever (38.5 to 41.0°C). His first WBC count was 26.9 × 10^9^/L. A tender, palpable right flank mass with an acute percussion pain was detected during a physical examination. His CT scan showed a solid hypo dense lesion in the right kidney measuring 7 × 10 cm (Figure [1](#F1){ref-type="fig"}B). Meanwhile, a right renal tumor was identified with no evidence of extra-renal extension or distant metastases. An open right radical nephrectomy was performed via a supra-11th rib right flank incision. The tumor was pathologically diagnosed as SRCC (Figure [2](#F2){ref-type="fig"}B). Postoperative recovery was uncomplicated and white blood cell decreased gradually to the normal range. However, two weeks later after the patient was discharged, he presented with a high fever again once more. Even though broad-spectrum antibiotics were administered without delay, the increasing speed of the WBC count was dramatic (Figure [3](#F3){ref-type="fig"}B). Leukemoid reaction was established and the patient died of multiple organ failure less than 50 days after the operation.

Conclusions
===========

Leukemoid reaction is firstly defined by Krumbhaar to describe a phenomenon concerning patients with blood findings that resembling some type of leukemia, but in whom leukemia is not confirmed through the subsequent course of the illness \[[@B1]\]. There is also a more restrictive definition in which the WBC count exceeding 40.000/ul is associated with a cause outside the bone marrow, or a certain proportion of blast cells are present in the blood \[[@B2]\]. Leukemoid reactions are probably caused by mechanical stimuli on bone marrow, resulting from bone metastases. They may also be caused by humoral stimuli resulting from neosynthesized blastic factors, or factors released from the foci of tumor necrosis.

Leukemoid reactions in carcinoma have often been described in association with carcinomas of the stomach, colon, liver, gall bladder, pancreas, lung, bladder, bone, and thyroid gland \[[@B3]-[@B8]\]. They have been reported in association with renal cell carcinoma RCC \[[@B9]\], but not with SRCC. To our knowledge, it is the first time that a leukemoid reaction has been reported in association with SRCC.

Both of the two patients had fever during the treatment and observation process. However, fever is an integral component of a leukemoid reaction, often associated with other paraneoplastic syndromes, resulting from either a release of endogenous pyrogens or due to necrotic-inflammatory phenomena of the tumor \[[@B10]\]. Standard antipyretic drugs and antibiotics are usually ineffective. Interleukin I (IL-1) and tumor necrotic factor (alpha) centrally acting on the thermoregulatory center of the hypothalamus are the major endogenous pyrogens \[[@B11],[@B12]\].

A granulocyte colony-stimulating factor (G-CSF) driven reaction is usually seen in advanced local or metastatic disease. It is thought to be associated with tumor progression and necrosis. With the function of this auto--production hematopoietic growth factor, precursor cells in the bone marrow are stimulated to proliferation and maturation into fully differentiated neutrophils \[[@B13],[@B14]\]. Generally, the WBC count will decrease to the normal range if the cause of a leukemoid reaction is eliminated. However, in these two patients, tumor resection did not result in the return of the WBC count. The final WBC count before death was extremely high.

Sarcomatoid differentiation of RCC occurs in all histologic subtypes of RCC, with the incidence ranging from 1.2% to 23.6% \[[@B15]\]. It is uniformly associated with a poor prognosis, with a median survival ranging from 2 to 9 months \[[@B15]-[@B17]\]. Surgery, alone, is often inadequate to cure patients, although there is no proven rule for adjuvant therapy. We performed a review of SRCC treatment these 10 years, finding that there was a case report indicating that sunitinib could be helpful for advanced SRCC \[[@B18]\]. Whether the application of tyrosin-kinase inhibitors such as sunitinib would be beneficial for a leukemoid reaction in SRCC is unclear, but worth trying.

These two cases indicate that leukemoid reaction may be a predictor of prognosis in patients with SRCC. Due to most of the patients with a malignant leukemoid reaction having a poor prognosis, it should always keep in mind that the sarcomatoid possibility of the tumor origin when there is an unknown etiology of leukecytosis, especially when infection is not likely. Clearly, more data and evidence are still needed to carry out extensive hematological diagnostic tests in order to distinguish the cause of the leukemoid reaction which would make it easier to find an effective adjuvant therapy.
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